CircRNA锌指RNA结合蛋白在恶性肿瘤中作用研究进展

doi:10.16352/j.issn.1001-6325.2022.10.1585

基础医学与临床 ›› 2022, Vol. 42 ›› Issue (10): 1585-1590.doi: 10.16352/j.issn.1001-6325.2022.10.1585

CircRNA锌指RNA结合蛋白在恶性肿瘤中作用研究进展

刘浪, 王海存, 高欣, 刘广麟, 赵俞乔, 姜兴明^*

哈尔滨医科大学附属第二医院肝胆胰外科, 黑龙江哈尔滨 150086

收稿日期:2021-07-15 修回日期:2021-11-11 出版日期:2022-10-05 发布日期:2022-09-23
通讯作者: * xmjiang@hrbmu.edu.cn
基金资助:
黑龙江省自然科学基金(LH2020H058);湖北陈孝平科技发展基金(CXPJJH12000002-2020015);国家自然科学基金(81602088)

Research progress of circular RNA zinc finger RNA binding protein in malignant tumors

LIU Lang, WANG Hai-cun, GAO Xin, LIU Guang-lin, ZHAO Yu-qiao, JIANG Xing-ming^*

Department of Hepatopancreatobiliary Surgery, the Second Affiliated Hospital of Harbin Medical University, Harbin 150086, China

Received:2021-07-15 Revised:2021-11-11 Online:2022-10-05 Published:2022-09-23
Contact: * xmjiang@hrbmu.edu.cn

摘要/Abstract

摘要： 环状RNA是一类具有特殊共价闭合环状结构的RNA分子,环状RNA锌指核糖核酸结合蛋白(circRNA-ZFR)在诸多恶性肿瘤中呈异常表达,并且其表达水平与肿瘤临床分期、癌细胞转移及患者预后密切相关;circRNA-ZFR可通过内源竞争性吸附miRNA、调节细胞周期、激活多种信号通路等机制参与调控肿瘤的发生发展。深入研究circRNA-ZFR在恶性肿瘤中的表达及作用机制有助于相关肿瘤的早期诊断、靶向治疗和患者预后评估。

关键词: 环状RNA, 环状RNA锌指RNA结合蛋白(circRNA-ZFR), 肿瘤, 表达, 机制

Abstract: Circular RNA is a kind of RNA molecule with special covalent closed circular structure. The existing research results showed that circular RNA zinc finger RNA binding protein (circRNA-ZFR) was abnormally expressed in many malignant tumors, and its expression level was closely related to tumor clinical stage, cell metastasis and patient prognosis. circRNA-ZFR could participate in the regulation of tumor occurrence and development through endogenous competitive adsorption of miRNA, regulation of cell cycle and activation of multiple signal pathways. Further study on the expression and mechanisms of circRNA-ZFR in malignant tumors may support early diagnosis, targeted therapy of related tumors and patients' prognosis.

Key words: circular RNA, circular RNA zinc finger RNA binding protein (circRNA-ZFR), tumors, expression, mechanisms

中图分类号:

刘浪, 王海存, 高欣, 刘广麟, 赵俞乔, 姜兴明. CircRNA锌指RNA结合蛋白在恶性肿瘤中作用研究进展[J]. 基础医学与临床, 2022, 42(10): 1585-1590.

LIU Lang, WANG Hai-cun, GAO Xin, LIU Guang-lin, ZHAO Yu-qiao, JIANG Xing-ming. Research progress of circular RNA zinc finger RNA binding protein in malignant tumors[J]. Basic & Clinical Medicine, 2022, 42(10): 1585-1590.

参考文献 25

[1]	Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68: 394-424.
[2]	赵俞乔, 苏志雷, 崔云甫, 等. 恶性肿瘤中HOTAIRM1的调控作用及机制[J]. 基础医学与临床, 2021, 41: 262-266.
[3]	Wu P, Mo YZ, Peng M, et al. Emerging role of tumor-related functional peptides encoded by lncRNA and circRNA[J]. Mol Cancer, 2020, 19: 22-36.
[4]	Sun DS, Guan CH, Wang WN, et al. LncRNA NORAD promotes proliferation, migration and angiogenesis of hepatocellular carcinoma cells through targeting miR-211-5p/FOXD1/VEGF-A axis[J]. Microvasc Res, 2020, 134: 104120. doi: 10.1016/j.mvr.2020.104120.
[5]	Della Bella E, Menzel U, Basoli V, et al. Differential regulation of circRNA, miRNA, and piRNA during early osteogenic and chondrogenic differentiation of human mesenchymal stromal cells[J]. Cells, 2020, 9: 398-422.
[6]	Chen Z, Wang F, Xiong YY, et al. CircZFR functions as a sponge of miR-578 to promote breast cancer progression by regulating HIF1A expression[J]. Cancer Cell Int, 2020, 20: 400-413.
[7]	Wei H, Pan L, Tao DY, et al. Circular RNA circZFR contributes to papillary thyroid cancer cell proliferation and invasion by sponging miR-1261 and facilitating C8orf4 expression[J]. Biochem Biophys Res Commun, 2018, 503: 56-61.
[8]	Wang M, Gao YS, Liu J. Silencing circZFR inhibits the proliferation, migration and invasion of human renal carcinoma cells by regulating miR-206[J]. Onco Targets Ther, 2019, 12: 7537-7550.
[9]	Zhang WY, Liu QH, Wang TJ, et al. CircZFR serves as a prognostic marker to promote bladder cancer progression by regulating miR-377/ZEB2 signaling[J]. Biosci Rep, 2019, 39: BSR20192779. doi: 10.1042/BSR20192779.
[10]	Zhan T, Rindtorff N, Boutros M. Wnt signaling in cancer[J]. Oncogene, 2017, 36: 1461-1473.
[11]	Luo LP, Miao PP, Ming Y, et al. Circ-ZFR promotes progression of bladder cancer by upregulating WNT5A via sponging miR-545 and miR-1270[J]. Front Oncol, 2021, 10: 596623. doi: 10.3389/fonc.2020.596623.
[12]	Folkman J. Role of angiogenesis in tumor growth and metastasis[J]. Semin Oncol, 2002, 29: 15-18.
[13]	Fang N, Shi YJ, Fan Y, et al. Circ_0072088 promotes proliferation, migration, and invasion of esophageal squamous cell cancer by absorbing miR-377[J]. J Oncol, 2020, 2020: 8967126. doi: 10.1155/2020/8967126.
[14]	Zhou MY, Yang Z, Wang DB, et al. The circular RNA circZFR phosphorylates Rb promoting cervical cancer progression by regulating the SSBP1/CDK2/cyclin E1 complex[J]. J Exp Clin Cancer Res, 2021, 40: 48-60.
[15]	Tan AC, Li QX, Chen LZ. CircZFR promotes hepatocellular carcinoma progression through regulating miR-3619-5p/CTNNB1 axis and activating Wnt/β-catenin pathway[J]. Arch Biochem Biophys, 2019, 661: 196-202.
[16]	Yang X, Liu L, Zou H, et al. circZFR promotes cell proliferation and migration by regulating miR-511/AKT1 axis in hepatocellular carcinoma[J]. Dig Liver Dis, 2019, 51: 1446-1455.
[17]	关沧海, 钟翔宇, 邰升, 等. 小核仁RNA宿主基因20在肿瘤中的表达及意义[J]. 临床误诊误治, 2021, 34: 112-116.
[18]	Cedric BC, Souraka TDM, Feng YL, et al. CircRNA ZFR stimulates the proliferation of hepatocellular carcinoma through upregulating MAP2K1[J]. Eur Rev Med Pharmacol Sci, 2020, 24: 9924-9931.
[19]	Xu R, Yin SW, Zheng M, et al. Circular RNA circZFR promotes hepatocellular carcinoma progression by regulating miR-375/HMGA2 axis[J]. Dig Dis Sci, 2021,66:4361-4373.
[20]	Tan ZF, Cao F, Jia B, et al. Circ_0072088 promotes the development of non-small cell lung cancer via the miR-377-5p/NOVA2 axis[J]. Thorac Cancer, 2020, 11: 2224-2236.
[21]	Zhang HF, Wang XL, Hu BL, et al. Circular RNA ZFR accelerates non-small cell lung cancer progression by acting as a miR-101-3p sponge to enhance CUL4B expression[J]. Artif Cells Nanomed Biotechnol, 2019, 47: 3410-3416.
[22]	Li HP, Liu FF, Qin WJ. Circ_0072083 interference enhances growth-inhibiting effects of cisplatin in non-small-cell lung cancer cells via miR-545-3p/CBLL1 axis[J]. Cancer Cell Int, 2020, 20: 78-91.
[23]	Li JM, Fan R, Xiao H. Circ_ZFR contributes to the paclitaxel resistance and progression of non-small cell lung cancer by upregulating KPNA4 through sponging miR-195-5p[J]. Cancer Cell Int, 2021, 21: 15-30.
[24]	Liu TL, Liu S, Xu Y, et al. Circular RNA-ZFR inhibited cell proliferation and promoted apoptosis in gastric cancer by sponging miR-130a/miR-107 and modulating PTEN[J]. Cancer Res Treat, 2018, 50: 1396-1417.
[25]	Bian LJ, Zhi XF, Ma LL, et al. Hsa_circRNA_103809 regulated the cell proliferation and migration in colorectal cancer via miR-532-3p/FOXO4 axis[J]. Biochem Biophys Res Commun, 2018, 505: 346-352.

CircRNA锌指RNA结合蛋白在恶性肿瘤中作用研究进展

Research progress of circular RNA zinc finger RNA binding protein in malignant tumors

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 25

相关文章 15

编辑推荐

Metrics

本文评价

[1]	苏凌峰, 王虎霞, 王延峰, 宋张骏. 慢性压力对乳腺癌发展的影响[J]. 基础医学与临床, 2024, 44(9): 1303-1307.
[2]	夏雨佳, 杨振丽, 刘玉琴. 肿瘤类器官临床前转化研究及应用[J]. 基础医学与临床, 2024, 44(9): 1214-1218.
[3]	刘保清, 黄容, 卢艳, 李凯, 张宁, 刘长征, 宋伟. 胃癌类器官在基础研究与临床应用中的进展[J]. 基础医学与临床, 2024, 44(9): 1219-1222.
[4]	彭晴怡, 许岭翎. 1型糖尿病诱发肌少症的研究进展[J]. 基础医学与临床, 2024, 44(8): 1189-1193.
[5]	李佩娟, 王春梅, 赵茜. 三七总皂苷预防血栓的机制[J]. 基础医学与临床, 2024, 44(7): 912-915.
[6]	李阳, 朱蕾. 真核延伸因子2激酶是治疗肿瘤的潜在新靶标[J]. 基础医学与临床, 2024, 44(7): 1039-1043.
[7]	陈笑天, 陈翀, 罗云萍. MAFB对肿瘤相关巨噬细胞极化及功能的影响[J]. 基础医学与临床, 2024, 44(7): 965-973.
[8]	谭树芬, 何利平, 杨琳琳, 杨谢兰, 杨宏英, 姚明姣, 李树清. TBL与工作坊整合教学法在妇科肿瘤学临床教学中的应用[J]. 基础医学与临床, 2024, 44(7): 1054-1057.
[9]	周玥, 童安莉. 嗜铬细胞瘤/副神经节瘤免疫微环境[J]. 基础医学与临床, 2024, 44(6): 742-747.
[10]	刘晶华, 卢琳. 肾上腺皮质癌基因及分子机制[J]. 基础医学与临床, 2024, 44(6): 748-752.
[11]	张沥元, 杜函泽, 潘慧. 治疗下丘脑性肥胖的药物研究进展[J]. 基础医学与临床, 2024, 44(5): 729-732.
[12]	王婷婷, 郭丹, 陆君阳, 徐徕, 董海涛, 林佃新, 肖毅. 结直肠神经内分泌肿瘤细胞突变类型分析[J]. 基础医学与临床, 2024, 44(4): 523-527.
[13]	王子豪, 夏小超, 李舜. 跨膜蛋白质在恶性肿瘤中作用的研究进展[J]. 基础医学与临床, 2024, 44(3): 398-402.
[14]	吴玉红, 喻才元, 叶石才. NMES1基因在恶性肿瘤中作用的研究进展[J]. 基础医学与临床, 2024, 44(3): 403-407.
[15]	南璐, 郭梦杰, 高雅楠, 贾红燕. 膜联蛋白A家族成员在乳腺癌中作用机制的研究进展[J]. 基础医学与临床, 2024, 44(3): 393-397.